Trial intelligence / Profile preview

Pre-operative Cisplatin, Irinotecan and Radiotherapy for Esophageal Cancer

NCT00160875Phase 3Completed

Sponsor
University Health Network
Start
Apr 2009
Primary completion
Mar 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of irinotecan in esophageal cancer, sponsored by University Health Network. Started Apr 2009; status: completed.

02

Drugs

irinotecan
03

Conditions

esophageal cancer

Beyond the preview

Go deeper on NCT00160875.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00160875.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call